Gift Echefu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Gift Echefu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Adekunle Kiladejo
Division of Cardiology, Holyname Medical Center, Newark, New Jersey
1 shared publication - Ashley Zboril
Internal Medicine Residency Program, Baton Rouge Medical Center, Baton Rouge, USA
1 shared publication - Catalina Negulescu
Internal Medicine, Baton Rouge General, Baton Rouge, USA
1 shared publication - Chukwuka Elendu
University of Ghana
1 shared publication - Jennifer L. Miatech
Baton Rouge General Internal Medicine Residency Program, Baton Rouge General Medical Center, Baton Rouge, LA, USA
1 shared publication - Karthik Reddy
Hospital Medicine, Baton Rouge General Medical Center, Baton Rouge, USA
1 shared publication
Latest Publications
- Open Access
- 18 July 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (9) , 5720-5734
Artificial intelligence in interventional cardiology: a review of its role in diagnosis, decision-making, and procedural precision
Cardiovascular diseases significantly burden healthcare systems globally, necessitating innovative solutions to enhance diagnosis, treatment, and patient management. Artificial intelligence (AI) is no longer a distant promise in interventional cardiology but a rapidly emerging tool with growing clinical impact. AI-driven technologies can analyze vast amounts of clinical data, recognize intricate patterns, and generate clinically relevant, evidence-based recommendations, augmenting physician expertise and streamlining care. In diagnostics, AI enhances imaging interpretation and lesion assessment, while procedurally, it supports real-time guidance and catheter-based interventions. Its integration into decision support systems has improved risk stratification, early disease detection, and individualized treatment planning. AI also advances personalized medicine using predictive models to tailor interventions to patient-specific needs. Despite its promise, challenges such as costs, ethical issues, and the need for rigorous validation remain barriers to widespread adoption. Nevertheless, as AI advances, its integration into interventional cardiology is expected to transform care delivery, optimize outcomes, and improve system efficiency.
- 18 July 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (9) , 5720-5734
Open AccessArtificial intelligence in interventional cardiology: a review of its role in diagnosis, decision-making, and procedural precision
Cardiovascular diseases significantly burden healthcare systems globally, necessitating innovative solutions to enhance diagnosis, treatment, and patient management. Artificial intelligence (AI) is no longer a distant promise in interventional cardiology but a rapidly emerging tool with growing clinical impact. AI-driven technologies can analyze vast amounts of clinical data, recognize intricate patterns, and generate clinically relevant, evidence-based recommendations, augmenting physician expertise and streamlining care. In diagnostics, AI enhances imaging interpretation and lesion assessment, while procedurally, it supports real-time guidance and catheter-based interventions. Its integration into decision support systems has improved risk stratification, early disease detection, and individualized treatment planning. AI also advances personalized medicine using predictive models to tailor interventions to patient-specific needs. Despite its promise, challenges such as costs, ethical issues, and the need for rigorous validation remain barriers to widespread adoption. Nevertheless, as AI advances, its integration into interventional cardiology is expected to transform care delivery, optimize outcomes, and improve system efficiency.
- Open Access
- 28 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e26420
Tainted Love: A Case of Gonococcal Endocarditis
Gonococcal endocarditis (GE) is a rare complication of disseminated gonococcal infection with significant morbidity and increasing mortality despite early diagnosis and surgical intervention. The discovery and use of antibiotics in the treatment of gonococcal infections has made this once relatively common entity a rarity. Notably, over the recent years, GE has shown an alarming resurgence for unclear reasons. The upward trend in the incidence of gonococcal infections coupled with observed antibiotic resistance may in part explain the rise in cases. GE mostly affects sexually active young people without a history of valvular heart disease. Prompt diagnosis and surgical intervention are important in the bid to mitigate poor outcomes. Management is therefore multidisciplinary; primary care clinicians who usually are the first to see this patient population should be able to make an early diagnosis and facilitate early referral for surgical intervention as indicated. Despite appropriate and timely therapy, devastating consequences of this condition are not uncommon.
- 28 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e26420
Open AccessTainted Love: A Case of Gonococcal Endocarditis
Gonococcal endocarditis (GE) is a rare complication of disseminated gonococcal infection with significant morbidity and increasing mortality despite early diagnosis and surgical intervention. The discovery and use of antibiotics in the treatment of gonococcal infections has made this once relatively common entity a rarity. Notably, over the recent years, GE has shown an alarming resurgence for unclear reasons. The upward trend in the incidence of gonococcal infections coupled with observed antibiotic resistance may in part explain the rise in cases. GE mostly affects sexually active young people without a history of valvular heart disease. Prompt diagnosis and surgical intervention are important in the bid to mitigate poor outcomes. Management is therefore multidisciplinary; primary care clinicians who usually are the first to see this patient population should be able to make an early diagnosis and facilitate early referral for surgical intervention as indicated. Despite appropriate and timely therapy, devastating consequences of this condition are not uncommon.
- Open Access
- 17 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e26053
Sphingobacterium Spritivorum Associated With Spontaneous Bacterial Peritonitis in a Cirrhotic Patient With Gram-Positive Bacteremia
Sphingobacterium spritivorum (SS) is a ubiquitous gram-negative organism and an uncommon cause of infection in humans. To our knowledge, there are no reported cases of this bacterium causing spontaneous bacterial peritonitis (SBP) in patients with cirrhosis. In this report, we discuss a case of a male patient in his late 60s who presented with severe sepsis from methicillin-resistant staphylococcus aureus (MRSA), in whom SS was subsequently identified via ascitic fluid culture. This unusual organism is known to have an innate resistance to multiple antibiotics and can cause life-threatening sepsis in cases of delayed or missed diagnosis. Clinicians should not be weighed down by anchoring bias and look for alternative, uncommon gram-negative organisms in cases of progressive sepsis in patients with ascites.
- 17 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e26053
Open AccessSphingobacterium Spritivorum Associated With Spontaneous Bacterial Peritonitis in a Cirrhotic Patient With Gram-Positive Bacteremia
Sphingobacterium spritivorum (SS) is a ubiquitous gram-negative organism and an uncommon cause of infection in humans. To our knowledge, there are no reported cases of this bacterium causing spontaneous bacterial peritonitis (SBP) in patients with cirrhosis. In this report, we discuss a case of a male patient in his late 60s who presented with severe sepsis from methicillin-resistant staphylococcus aureus (MRSA), in whom SS was subsequently identified via ascitic fluid culture. This unusual organism is known to have an innate resistance to multiple antibiotics and can cause life-threatening sepsis in cases of delayed or missed diagnosis. Clinicians should not be weighed down by anchoring bias and look for alternative, uncommon gram-negative organisms in cases of progressive sepsis in patients with ascites.